AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more

AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more

Source: 
Fierce Pharma
snippet: 

At first glance, it seems like a logical idea: pharma companies teaching doctors' staff how to handle patients using their drugs and helping staffers with reimbursement questions. But a slew of companies are discovering that it's not so simple.

In fact, it might just be against the law.